Developing a vaccine against ETEC in young children has long been a global health challenge. We are now closer than ever to changing that. At Scandinavian Biopharma, we are advancing what could become the world’s first vaccine to protect young children against ETEC—a major cause of diarrhoeal disease affecting millions globally. The progress highlighted by EDCTP […]
Scientific American has highlighted ETVAX, our oral vaccine candidate targeting enterotoxigenic E. coli (ETEC) — one of the leading causes of severe diarrhoea in young children in low- and middle-income countries. The coverage follows the recent publication of our Phase 2b results in The Lancet Infectious Diseases and reflects growing recognition of the urgent need […]
Scandinavian Biopharma today announces that the comprehensive results from its Phase 2b trial of ETVAX®, the lead oral vaccine candidate against enterotoxigenic Escherichia coli (ETEC), have been published in The Lancet Infectious Diseases, one of the world’s foremost peer-reviewed medical journals. The peer-reviewed publication provides detailed analysis of the trial’s safety, immunogenicity, and efficacy outcomes […]
Scandinavian Biopharma is pleased to announce another year of strong growth, strategic milestones and key achievements. For the full year 2024, the company’s revenue reached 161 MSEK, reflecting continued momentum in both its distribution and development business. The company’s distribution business achieved its strongest sales performance to date, driven by the introduction of new products […]
Scandinavian Biopharma is pleased to announce the successful completion of its large pediatric Phase IIb trial for ETVAX®, a promising vaccine candidate against enterotoxigenic Escherichia coli (ETEC), commonly called traveler’s diarrhea, conducted in The Gambia. The promising findings from this study are a significant step forward in the mission to provide an essential ETEC vaccine […]
This week, 23rd – 27th September, Scandinavian Bioharma is the guest editor for Stockholm Science City on Instagram, @sthlmscicity. Please join us, we have an exciting week in front of us! https://www.instagram.com/sthlmscicity/
